Table 2.
Characteristics of 16 RA patients included in the microarray assay
| Parameters | RA patients in microarray (N = 16) |
|---|---|
| Age (y) | 54.7 ± 9.9 |
| Gender, female (n/%) | 12 (75) |
| Disease duration (mo) | 48.0 (37.3‐60.5) |
| ESR (mm/h) | 34.6 (14.5‐41.0) |
| CRP (mg/L) | 33.2 (21.7‐48.5) |
| DAS28 score | 5.5 ± 0.8 |
| RF positive (n/%) | 14 (88) |
| ACPA positive (n/%) | 13 (81) |
| Biologics history | 3 (19) |
| Concomitant medications | |
| MTX (n/%) | 10 (63) |
| LEF (n/%) | 6 (37) |
Data were presented as mean value ± standard deviation, median (25th‐75th), or count (percentage).
Abbreviations: ACPA, anti‐citrullinated protein antibody; CRP, C‐reactive protein; DAS28, disease activity score in 28 joints; ESR, erythrocyte sedimentation rate; LEF, leflunomide; MTX, methotrexate; RA, rheumatoid arthritis; RF, rheumatoid factor.